These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 32005086)

  • 1. An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies.
    Jiang S; Du L; Shi Z
    Emerg Microbes Infect; 2020; 9(1):275-277. PubMed ID: 32005086
    [No Abstract]   [Full Text] [Related]  

  • 2. The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future.
    Li JY; You Z; Wang Q; Zhou ZJ; Qiu Y; Luo R; Ge XY
    Microbes Infect; 2020 Mar; 22(2):80-85. PubMed ID: 32087334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facing challenges with the novel coronavirus SARS-CoV-2 outbreak.
    van der Werf S; Peltekian C
    Virologie (Montrouge); 2020 Apr; 24(S1):e12-15. PubMed ID: 32186279
    [No Abstract]   [Full Text] [Related]  

  • 4. Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China.
    Yu F; Du L; Ojcius DM; Pan C; Jiang S
    Microbes Infect; 2020 Mar; 22(2):74-79. PubMed ID: 32017984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV.
    Lee PI; Hsueh PR
    J Microbiol Immunol Infect; 2020 Jun; 53(3):365-367. PubMed ID: 32035811
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronavirus SARS-CoV-2: filtering fact from fiction in the infodemic: Q&A with virologist Professor Urs Greber.
    Ruffell D
    FEBS Lett; 2020 Apr; 594(7):1127-1131. PubMed ID: 32246722
    [No Abstract]   [Full Text] [Related]  

  • 7. The Wuhan SARS-CoV-2-What's next for China.
    Lu H; Stratton CW; Tang YW
    J Med Virol; 2020 Jun; 92(6):546-547. PubMed ID: 32115732
    [No Abstract]   [Full Text] [Related]  

  • 8. The novel zoonotic COVID-19 pandemic: An expected global health concern.
    Contini C; Di Nuzzo M; Barp N; Bonazza A; De Giorgio R; Tognon M; Rubino S
    J Infect Dev Ctries; 2020 Mar; 14(3):254-264. PubMed ID: 32235085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The continued epidemic threat of SARS-CoV-2 and implications for the future of global public health.
    Sheahan TP; Frieman MB
    Curr Opin Virol; 2020 Feb; 40():37-40. PubMed ID: 32569751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. China is tightening its grip on coronavirus research.
    Silver A; Cyranoski D
    Nature; 2020 Apr; 580(7804):439-440. PubMed ID: 32296161
    [No Abstract]   [Full Text] [Related]  

  • 11. Contextualizing bats as viral reservoirs.
    Streicker DG; Gilbert AT
    Science; 2020 Oct; 370(6513):172-173. PubMed ID: 33033207
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful containment of COVID-19: the WHO-Report on the COVID-19 outbreak in China.
    Salzberger B; Glück T; Ehrenstein B
    Infection; 2020 Apr; 48(2):151-153. PubMed ID: 32185635
    [No Abstract]   [Full Text] [Related]  

  • 13. Monoclonal Antibodies for Prevention and Treatment of COVID-19.
    Marovich M; Mascola JR; Cohen MS
    JAMA; 2020 Jul; 324(2):131-132. PubMed ID: 32539093
    [No Abstract]   [Full Text] [Related]  

  • 14. Rigorous wildlife disease surveillance.
    Watsa M;
    Science; 2020 Jul; 369(6500):145-147. PubMed ID: 32646989
    [No Abstract]   [Full Text] [Related]  

  • 15. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
    Shanmugaraj B; Siriwattananon K; Wangkanont K; Phoolcharoen W
    Asian Pac J Allergy Immunol; 2020 Mar; 38(1):10-18. PubMed ID: 32134278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Hendra to Wuhan: what has been learned in responding to emerging zoonotic viruses.
    Wang LF; Anderson DE; Mackenzie JS; Merson MH
    Lancet; 2020 Feb; 395(10224):e33-e34. PubMed ID: 32059799
    [No Abstract]   [Full Text] [Related]  

  • 17. Strategies and implications for improving the cure rate of Novel Coronavirus Pneumonia in Wuhan.
    Zhang Y; Cao P; Meng J; Qiu J; Hu Q
    J Glob Health; 2020 Dec; 10(2):020302. PubMed ID: 33110506
    [No Abstract]   [Full Text] [Related]  

  • 18. [Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.].
    Lvov DK; Alkhovsky SV; Kolobukhina LV; Burtseva EI
    Vopr Virusol; 2020; 65(1):6-15. PubMed ID: 32496715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New SARS-like virus in China triggers alarm.
    Cohen J; Normile D
    Science; 2020 Jan; 367(6475):234-235. PubMed ID: 31949058
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19: a new challenge for human beings.
    Yang P; Wang X
    Cell Mol Immunol; 2020 May; 17(5):555-557. PubMed ID: 32235915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.